Cargando…

Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice

Glucagon-like peptide-1 (GLP-1) receptor agonists potentiate glucose-induced insulin secretion. In addition, they have been reported to increase pancreatic beta cell mass in diabetic rodents. However, the precise mode of action of GLP-1 receptor agonists still needs to be elucidated. Here we clarify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Kanako, Minami, Kohtaro, Kudo, Maya, Iemoto, Keisuke, Takahashi, Harumi, Seino, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418765/ https://www.ncbi.nlm.nih.gov/pubmed/25938469 http://dx.doi.org/10.1371/journal.pone.0126003

Ejemplares similares

Current status of regeneration of pancreatic β‐cells
por: Minami, Kohtaro, et al.
Publicado: (2013)

Pancreatic β-cell signaling: toward better understanding of diabetes and its treatment
por: SEINO, Susumu, et al.
Publicado: (2010)

Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin
por: Song, Imane, et al.
Publicado: (2015)

Tracing phenotypic reversibility of pancreatic β‐cells in vitro
por: Minami, Kohtaro, et al.
Publicado: (2010)

Glutamate as intracellular and extracellular signals in pancreatic islet functions
por: TAKAHASHI, Harumi, et al.
Publicado: (2019)

Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion
por: Murao, Naoya, et al.
Publicado: (2017)

A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent
por: Sugawara, Kenji, et al.
Publicado: (2016)

Establishment of new clonal pancreatic β‐cell lines (MIN6‐K) useful for study of incretin/cyclic adenosine monophosphate signaling
por: Iwasaki, Masahiro, et al.
Publicado: (2010)

Increased glycolysis affects β-cell function and identity in aging and diabetes
por: Murao, Naoya, et al.
Publicado: (2021)

In vitro generation of insulin‐secreting cells from human pancreatic exocrine cells
por: Minami, Kohtaro, et al.
Publicado: (2011)

Divergent Effects of Liraglutide, Exendin-4, and Sitagliptin on Beta-Cell Mass and Indicators of Pancreatitis in a Mouse Model of Hyperglycaemia
por: Mondragon, Angeles, et al.
Publicado: (2014)

Factors Influencing Experimental Candidiasis in Mice. I. Alloxan Diabetes
por: Andriole, Vincent T., et al.
Publicado: (1962)

Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference
por: Yabe, Daisuke, et al.
Publicado: (2011)

Antidiabetic potential of Caralluma europaea against alloxan-induced diabetes in mice
por: Dra, Loubna Ait, et al.
Publicado: (2019)

Liraglutide Overdose-Induced Acute Pancreatitis
por: AlSaadoun, Aljawhara R, et al.
Publicado: (2022)

THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT : I. THE INHIBITION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN ALLOXAN DIABETES II. THE EFFECT OF ALLOXAN DIABETES ON THE RETROGRESSION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS
por: Duff, G. Lyman, et al.
Publicado: (1949)

β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion
por: Yokoi, Norihide, et al.
Publicado: (2016)

Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
por: Ramadan, Basma K., et al.
Publicado: (2017)

The influence of alloxan diabetes on experimental cancer.
por: Garvie, W. H.
Publicado: (1968)

Alloxan: An unpredictable drug for diabetes induction?
por: Misra, Monika, et al.
Publicado: (2012)

Musa sapientum with exercises attenuates hyperglycemia and pancreatic islet cells degeneration in alloxan-diabetic rats
por: Akinlolu, Adelaja Abdulazeez, et al.
Publicado: (2015)

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial
por: Kuwata, Hitoshi, et al.
Publicado: (2015)

Experimental Cerebral Mucormycosis in Rabbits with Alloxan Diabetes
por: Bauer, Heinz, et al.
Publicado: (1955)

THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT : III. THE MECHANISM OF THE INHIBITION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN ALLOXAN-DIABETIC RABBITS
por: Duff, G. Lyman, et al.
Publicado: (1950)

THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT : IV. THE EFFECT OF INSULIN THERAPY ON THE INHIBITION OF ATHEROSCLEROSIS IN THE ALLOXAN-DIABETIC RABBIT
por: Duff, G. Lyman, et al.
Publicado: (1954)

Peroxiredoxin 6 Attenuates Alloxan-Induced Type 1 Diabetes Mellitus in Mice and Cytokine-Induced Cytotoxicity in RIN-m5F Beta Cells
por: Novoselova, Elena G., et al.
Publicado: (2020)

Antihyperglycemic Effects of Fermented and Nonfermented Mung Bean Extracts on Alloxan-Induced-Diabetic Mice
por: Yeap, Swee Keong, et al.
Publicado: (2012)

Effect of Potentilla fulgens on lipid peroxidation and antioxidant status in alloxan-induced diabetic mice
por: Saio, Valrielyn, et al.
Publicado: (2012)

In Vivo Hypoglycemic Effect of Kigelia africana (Lam): Studies With Alloxan-Induced Diabetic Mice
por: Njogu, Stephen M., et al.
Publicado: (2018)

Phytochemical Investigation and Therapeutical Potential of Cotinus coggygria Scop. in Alloxan-Induced Diabetic Mice
por: Rahman, Shahid, et al.
Publicado: (2022)

Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat
por: Hayami, Tomohide, et al.
Publicado: (2020)

Effects of DPP‐4 inhibitor linagliptin and GLP‐1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open‐label, 2‐arm parallel comparative, exploratory trial
por: Yabe, Daisuke, et al.
Publicado: (2016)

A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg
por: Seino, Yutaka, et al.
Publicado: (2022)

Atorvastatin reduces alloxan-induced impairment of aversive stimulus memory in mice
por: Kukula, Osman, et al.
Publicado: (2022)

Liraglutide-Induced Hemorrhagic Pancreatitis in a Nondiabetic Patient
por: Dolan, Russell D., et al.
Publicado: (2020)

Protective and curative effects of Cocos nucifera inflorescence on alloxan-induced pancreatic cytotoxicity in rats
por: Renjith, Raveendran S., et al.
Publicado: (2012)

Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice.
por: Yam, D., et al.
Publicado: (1990)

STUDIES ON GLYCOGEN NEPHROSIS IN ALLOXAN-TREATED DIABETIC RATS
por: Curtis, G. W., et al.
Publicado: (1947)

Protective role of Phyllanthusfraternus in alloxan-induced diabetes in rats
por: Singh, Hasandeep, et al.
Publicado: (2020)

Evaluation of metformin performance on alloxan-induced diabetic rabbits
por: Yasin, Youssef Shakuri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a49kpfv65u73hpdh3m36h0i1tn